These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7429678)

  • 21. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
    Khot V; DeVane CL; Korpi ER; Venable D; Bigelow LB; Wyatt RJ; Kirch DG
    J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pharmacokinetics of dihydroergotamine administered by nasal spray.
    Humbert H; Cabiac MD; Dubray C; Lavène D
    Clin Pharmacol Ther; 1996 Sep; 60(3):265-75. PubMed ID: 8841149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and oral bioavailability of pidotimod in humans.
    Mailland F; Coppi G; Silingardi S
    Arzneimittelforschung; 1994 Dec; 44(12A):1465-9. PubMed ID: 7857343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haloperidol dosing strategies.
    Volavka J
    Am J Psychiatry; 1996 Aug; 153(8):1108; author reply 1109. PubMed ID: 8678186
    [No Abstract]   [Full Text] [Related]  

  • 28. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
    Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
    Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ritodrine serum levels: influence of dose and route of administration.
    Van Lierde M; Desager JP; Harvengt C; Thomas K
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):382-5. PubMed ID: 6469427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steady-state plasma level prediction for haloperidol from a single test dose.
    Javaid JI; Janicak PG; Hedeker D; Sharma RP; Davis JM
    Psychopharmacol Bull; 1991; 27(1):83-8. PubMed ID: 1862210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
    Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
    Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasma level monitoring of psychotropic drugs in children. I-Haloperidol (author's transl)].
    Dugas M; Zarifian E; Le Heuzey MF; Regnier N; Durand G; Bianchetti G; Morselli PL
    Nouv Presse Med; 1982 Jun; 11(29):2201-4. PubMed ID: 7110982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
    Aschauer HN; Schönbeck G; Langer G; Koinig G; Resch F; Hatzinger R; Chaudry HR; Sieghart W
    Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study.
    Miller JL; Ashford JW; Archer SM; Rudy AC; Wermeling DP
    Pharmacotherapy; 2008 Jul; 28(7):875-82. PubMed ID: 18576902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioavailability of oral and intramuscular molindone hydrochloride in schizophrenic patients.
    Zetin M; Cramer M; Garber D; Plon L; Paulshock M; Hoffman HE; Schary WL
    Clin Ther; 1985; 7(2):169-75. PubMed ID: 3986861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodisposition of thiamphenicol in rabbits.
    Abd El-Aty AM; Abo El Sooud K; Goudah AM
    Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.